Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo

Klenke, Frank Michael; Abdollahi, Amir; Bischof, Marc; Gebhard, Martha-Maria; Ewerbeck, Volker; Huber, Peter E; Sckell, Axel (2011). Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo. Strahlentherapie und Onkologie, 187(1), pp. 45-51. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-010-2116-3

[img]
Preview
Text
s00066-010-2116-3.pdf - Published Version
Available under License Publisher holds Copyright.

Download (1MB) | Preview

Cyclooxygenase-2 (COX-2) inhibitors mediate a systemic antitumor activity via antiangiogenesis and seem to enhance the response of primary tumors to radiation. Radiosensitizing effects of COX-2 inhibition have not been reported for bone metastases. Therefore, the aim of this study was the investigation of the radiosensitizing effects of the selective COX-2 inhibitor celecoxib in secondary bone tumors of a non-small cell lung carcinoma in vivo.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Orthopaedic Surgery

UniBE Contributor:

Klenke, Frank M.

ISSN:

0179-7158

Publisher:

Springer-Medizin-Verlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:22

Last Modified:

05 Dec 2022 14:06

Publisher DOI:

10.1007/s00066-010-2116-3

PubMed ID:

21234531

Web of Science ID:

000286711600007

BORIS DOI:

10.48350/7421

URI:

https://boris.unibe.ch/id/eprint/7421 (FactScience: 212681)

Actions (login required)

Edit item Edit item
Provide Feedback